In this study, a single intramuscular (IM) 0.5 mL TP0463518 dose of Adacel was administered to healthy 14 days post-partum women who had delivered healthy full-term infants (1845 years of age) at the time of hospital discharge. in magnitude and breadth of antibody profile, consistent with history of vaccination. A longitudinal analysis of Tdap responses in women vaccinated post-partum exhibited a rapid increase in serum IgG that remained elevated for up to 24 months. Likewise, high levels of vaccine-specific IgA and IgG antibodies were present in breast milk, although they exhibited faster decay. This multiplex MSD assay is usually a reliable and practical tool for quantification of pertussis, tetanus, and diphtheria antibodies in serum and breast milk in serosurveys or vaccine studies. == IMPORTANCE == Pertussis (whooping cough) has reemerged in recent years. Vaccination during pregnancy is an effective approach to prevent illness during the first months of life. We developed a multiplex assay for quantification of pertussis, tetanus, and diphtheria serum antibodies using the Meso Scale Discovery (MSD) platform; the method was qualified, and specificity, precision, accuracy, linearity, and limits of quantification were defined. It was also adapted for quantification of antibodies in breast milk. We successfully decided serostatus in women from different regions and with different vaccination histories, as well as responses to Tdap in blood and breast milk post-partum. This is the first description of a multiplex assay for the quantification of pertussis, tetanus, and diphtheria antibodies in breast milk. KEYWORDS:pertussis, Tdap, maternal vaccines, multiplex, infant immunity, infant vaccines == INTRODUCTION == Pertussis (or whooping cough) is usually a severe and sometimes fatal respiratory contamination. The most vulnerable group is infants under 3 months of age who have not yet begun their primary vaccination series and have scant to no immunity (1). Despite high rates of routine immunization, the incidence of whooping cough has increased in recent years; this has been attributed to several factors, including short-lived immunity elicited by the acellular pertussis vaccine presently in use in high-income countries. Maternal immunization has been recommended in industrialized countries to boost maternal immunity and ensure that sufficient levels TP0463518 of antibodies are transferred to the infant via placenta and breast milk to shield them from contamination until they begin their primary vaccination series. Practical and reliable methods to assess pertussis immunity and responses to vaccination are greatly needed. Commercial serologic assays, typically used for diagnosis, lack information on assay components and performance, and do not meet the quality standards required for clinical study end point data. High throughput technologies for quantification of antibodies are attractive for expediency and conservation of specimens. There is special interest in practical methods suitable for the quantification of antibodies in different matrices, including mucosal secretions. Analysis of pertussis immunity in breast milk from mothers vaccinated during pregnancy or perinatally is usually important as maternal milk not only promotes infant growth but also contains a variety of immunological effectors, most importantly antibodies directed against potential pathogens. Features of human mucosal immunity against pertussis remain largely unknown. Antibodies TP0463518 in breast milk have been examined with limited scope (24). Bioanalytical tools to support clinical study endpoints require rigorous development and evaluation of performance. Herein we describe the development and qualification of a multiplex immunoassay for quantification of pertussis, tetanus, and diphtheria serum IgG using the Meso Scale Diagnostics (MSD) technology (5). The theory of this assay remains the same as CD9 the indirect enzyme-linked immunosorbent assay (ELISA), except that multiple antigens are immobilized on spatially distinct spots within a single well of a 96-well plate, and each spot produces a unique signal, allowing for simultaneous detection of multiple antibody specificities in a single test: tetanus (TT) and diphtheria toxoid (DT) as well asB. pertussistoxin (PT), filamentous hemagglutinin (FHA), pertactin (PRN), and fimbriae (FIM2/3) were included in our assay plates. The analytical assay qualification involved analysis of specificity, relative accuracy, and precision, dilutional linearity and parallelism, lower limits of quantification,.
